Jun Wang - Publications

Pharmaceutical Sciences State University of New York, Buffalo, Buffalo, NY, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Greene MK, Chen T, Robinson E, Straubinger NL, Minx C, Chan DKW, Wang J, Burrows JF, Van Schaeybroeck S, Baker JR, Caddick S, Longley DB, Mager DE, Straubinger RM, Chudasama V, et al. Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer. British Journal of Cancer. PMID 32913288 DOI: 10.1038/S41416-020-01046-6  0.574
2019 Wang J, Chan DK, Sen A, Ma WW, Straubinger RM. Tumor priming by SMO inhibition enhances antibody delivery and efficacy in a pancreatic ductal adenocarcinoma model. Molecular Cancer Therapeutics. PMID 31363010 DOI: 10.1158/1535-7163.Mct-18-0354  0.63
2019 Ci LQ, Huang ZG, Lv FM, Wang J, Feng LL, Sun F, Cao SJ, Liu ZP, Liu Y, Wei G, Lu WY. Enhanced Delivery of Imatinib into Vaginal Mucosa via a New Positively Charged Nanocrystal-Loaded in Situ Hydrogel Formulation for Treatment of Cervical Cancer. Pharmaceutics. 11. PMID 30621141 DOI: 10.3390/pharmaceutics11010015  0.319
2018 Huang ZG, Lv FM, Wang J, Cao SJ, Liu ZP, Liu Y, Lu WY. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability. International Journal of Pharmaceutics. PMID 30557679 DOI: 10.1016/j.ijpharm.2018.12.023  0.372
2018 Chan D, Minx C, Wang J, Sen A, Johnston M, Ma WW, Scott CJ, Straubinger RM. Abstract 3704: Efficacy of DR5-targeted immunoliposomes in pancreatic cancer models primed with SMO inhibitors Cancer Research. 78: 3704-3704. DOI: 10.1158/1538-7445.Am2018-3704  0.628
2014 Wang J, Qu Y, Pitoniak R, Trueman-Fatallah SA, Hylander BL, Repasky EA, Ma WW, Straubinger RM. Abstract 2691: Smo-targeted sonic hedgehog signaling inhibitor enhances therapeutic antibody deposition and efficacy in a patient-derived pancreatic ductal adenocarcinoma model Cancer Research. 74: 2691-2691. DOI: 10.1158/1538-7445.Am2014-2691  0.638
2002 Su MY, Samoszuk MK, Wang J, Nalcioglu O. Assessment of protamine-induced thrombosis of tumor vessels for cancer therapy using dynamic contrast-enhanced MRI. Nmr in Biomedicine. 15: 106-13. PMID 11870906 DOI: 10.1002/Nbm.730  0.326
Show low-probability matches.